SEC Form 4 · accession 0001179110-17-007429
ABBOTT LABORATORIES · ABT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sean Shrimpton
Officer — Senior Vice President
Period of report
May 15, 2017
Accepted (ET)
May 17, 2017 · 5:06 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000001800
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option (right to buy)F1 | $44.08 | May 15, 2017 | A | 92,032 | A | May 15, 2018 | May 14, 2027 | Common shares | 92,032 | 92,032 | D |
Explanation of responses
- F1Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 30,678 on 5/15/2018, 30,677 on 5/15/2019, and 30,677 on 5/15/2020.